{"disease":{"id":"third-generation-tki","name":"third generation tki"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06613633","title":"Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC","phase":"","overall_status":"COMPLETED","enrollment_count":4000,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05663177","title":"Almonertinib Plus Metronomic Oral Vinorelbine","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT05497076","title":"the Efficacy and Safety of Dalpiciclib Combined With Third-generation EGFR-TKI in Patients With EGFR Mutation and Meningial Metastasis in Non-small Cell Lung Cancer Progressing Through Third-generation TKI and Platinum-containing Two-drug Chemotherapy","phase":"","overall_status":"UNKNOWN","enrollment_count":9,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT05604755","title":"Prophylactic HQP1351 Therapy Post-transplants on Leukemia After Allo-HSCT","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"xuna","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}